In focus · trending topic

metabolic diseases

2 stories · following the connections

Crinetics Pharmaceuticals to Present at Cowen and Company 38th Annual Health Care Conference

By Nasdaq OMXMar 7, 2018, 9:06 PM UTC

Crinetics Pharmaceuticals Awarded Two SBIR Grants to Develop New Therapeutics for Congenital Hyperinsulinism and Cushing’s Disease

By Nasdaq OMXSep 6, 2017, 1:01 PM UTC